Document Type

Patent

Publication Date

11-28-2017

Keywords

oregon

Abstract

OX40 is a potent immune stimulating target . Provided herein are methods for the treatment of cancer patients using ( 3X40 agonists methods to predict clinical outcome of the treatment by correlation of the treatment and an increase in OX40 - induced T cell proliferation .

Area of Special Interest

Cancer

Specialty/Research Institute

Oncology

Comments

Patent No.: US 9,828,432 B2

Assignee

PROVIDENCE HEALTH & SERVICES-OREGON Renton, WA (US)

Serial Number

14 / 376 , 998

Download

Included in

Oncology Commons

Share

COinS